SCYNEXIS, Inc. Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share
SCYNEXIS, Inc. (SCYX) reported Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share of $0.00 per share for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare · last filed 2017-03-13
- SCYNEXIS, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2016-06-30 was $0.00.
- SCYNEXIS, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2016-03-31 was $0.00.
- SCYNEXIS, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2015-09-30 was -$0.06, a 220.00% decline year-over-year.
- SCYNEXIS, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2015-06-30 was -$0.25, a 327.27% decline year-over-year.
- SCYNEXIS, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2016 was $0.00.
- SCYNEXIS, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2015 was -$0.35, a 245.83% decline from fiscal 2014.
- SCYNEXIS, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2014 was $0.24.
| Period end | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 3 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 6 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 9 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-13 | |||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | -$0.35 10-K · filed 2017-03-13 | |||
| 2015-09-30 | -$0.06 10-Q · filed 2015-11-13 | -$0.37 10-Q · filed 2015-11-13 | ||
| 2015-06-30 | -$0.25 10-Q · filed 2016-08-08 | -$0.33 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | -$0.05 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $0.24 10-K · filed 2017-03-13 | |||
| 2014-09-30 | $0.05 10-Q · filed 2015-11-13 | $0.23 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | $0.11 10-Q · filed 2015-08-19 | $0.45 10-Q · filed 2015-08-19 | ||
| 2014-03-31 | $1.10 8-K · filed 2015-10-30 | |||
| 2013-12-31 | $2.59 8-K · filed 2015-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |